The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prefilled Syringes Drug Market Research Report 2025
Synopsis
The global Prefilled Syringes Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prefilled Syringes Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prefilled Syringes Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prefilled Syringes Drug include Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Fresenius Kabi AG, Johnson & Johnson, Sanofi and Merck & Co. Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prefilled Syringes Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prefilled Syringes Drug.
Report Scope
The Prefilled Syringes Drug market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prefilled Syringes Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prefilled Syringes Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
AstraZeneca plc
Mylan N.V.
Pfizer
Fresenius Kabi AG
Johnson & Johnson
Sanofi
Merck & Co. Inc.
Novartis AG
Segment by Type
Vaccines
Insulin
Adrenaline
Opioids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prefilled Syringes Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prefilled Syringes Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Prefilled Syringes Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prefilled Syringes Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prefilled Syringes Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prefilled Syringes Drug include Amgen Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Mylan N.V., Pfizer, Fresenius Kabi AG, Johnson & Johnson, Sanofi and Merck & Co. Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prefilled Syringes Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prefilled Syringes Drug.
Report Scope
The Prefilled Syringes Drug market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prefilled Syringes Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prefilled Syringes Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen Inc.
Teva Pharmaceutical Industries Ltd.
AstraZeneca plc
Mylan N.V.
Pfizer
Fresenius Kabi AG
Johnson & Johnson
Sanofi
Merck & Co. Inc.
Novartis AG
Segment by Type
Vaccines
Insulin
Adrenaline
Opioids
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prefilled Syringes Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prefilled Syringes Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prefilled Syringes Drug Market Overview
1.1 Product Overview and Scope of Prefilled Syringes Drug
1.2 Prefilled Syringes Drug Segment by Type
1.2.1 Global Prefilled Syringes Drug Market Value Comparison by Type (2024-2030)
1.2.2 Vaccines
1.2.3 Insulin
1.2.4 Adrenaline
1.2.5 Opioids
1.2.6 Others
1.3 Prefilled Syringes Drug Segment by Application
1.3.1 Global Prefilled Syringes Drug Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Drug Stores
1.4 Global Prefilled Syringes Drug Market Size Estimates and Forecasts
1.4.1 Global Prefilled Syringes Drug Revenue 2019-2030
1.4.2 Global Prefilled Syringes Drug Sales 2019-2030
1.4.3 Global Prefilled Syringes Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prefilled Syringes Drug Market Competition by Manufacturers
2.1 Global Prefilled Syringes Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prefilled Syringes Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prefilled Syringes Drug Average Price by Manufacturers (2019-2024)
2.4 Global Prefilled Syringes Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prefilled Syringes Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prefilled Syringes Drug, Product Type & Application
2.7 Prefilled Syringes Drug Market Competitive Situation and Trends
2.7.1 Prefilled Syringes Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prefilled Syringes Drug Players Market Share by Revenue
2.7.3 Global Prefilled Syringes Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prefilled Syringes Drug Retrospective Market Scenario by Region
3.1 Global Prefilled Syringes Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prefilled Syringes Drug Global Prefilled Syringes Drug Sales by Region: 2019-2030
3.2.1 Global Prefilled Syringes Drug Sales by Region: 2019-2024
3.2.2 Global Prefilled Syringes Drug Sales by Region: 2025-2030
3.3 Global Prefilled Syringes Drug Global Prefilled Syringes Drug Revenue by Region: 2019-2030
3.3.1 Global Prefilled Syringes Drug Revenue by Region: 2019-2024
3.3.2 Global Prefilled Syringes Drug Revenue by Region: 2025-2030
3.4 North America Prefilled Syringes Drug Market Facts & Figures by Country
3.4.1 North America Prefilled Syringes Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prefilled Syringes Drug Sales by Country (2019-2030)
3.4.3 North America Prefilled Syringes Drug Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prefilled Syringes Drug Market Facts & Figures by Country
3.5.1 Europe Prefilled Syringes Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prefilled Syringes Drug Sales by Country (2019-2030)
3.5.3 Europe Prefilled Syringes Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prefilled Syringes Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Prefilled Syringes Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prefilled Syringes Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Prefilled Syringes Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prefilled Syringes Drug Market Facts & Figures by Country
3.7.1 Latin America Prefilled Syringes Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prefilled Syringes Drug Sales by Country (2019-2030)
3.7.3 Latin America Prefilled Syringes Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prefilled Syringes Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Prefilled Syringes Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prefilled Syringes Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prefilled Syringes Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prefilled Syringes Drug Sales by Type (2019-2030)
4.1.1 Global Prefilled Syringes Drug Sales by Type (2019-2024)
4.1.2 Global Prefilled Syringes Drug Sales by Type (2025-2030)
4.1.3 Global Prefilled Syringes Drug Sales Market Share by Type (2019-2030)
4.2 Global Prefilled Syringes Drug Revenue by Type (2019-2030)
4.2.1 Global Prefilled Syringes Drug Revenue by Type (2019-2024)
4.2.2 Global Prefilled Syringes Drug Revenue by Type (2025-2030)
4.2.3 Global Prefilled Syringes Drug Revenue Market Share by Type (2019-2030)
4.3 Global Prefilled Syringes Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prefilled Syringes Drug Sales by Application (2019-2030)
5.1.1 Global Prefilled Syringes Drug Sales by Application (2019-2024)
5.1.2 Global Prefilled Syringes Drug Sales by Application (2025-2030)
5.1.3 Global Prefilled Syringes Drug Sales Market Share by Application (2019-2030)
5.2 Global Prefilled Syringes Drug Revenue by Application (2019-2030)
5.2.1 Global Prefilled Syringes Drug Revenue by Application (2019-2024)
5.2.2 Global Prefilled Syringes Drug Revenue by Application (2025-2030)
5.2.3 Global Prefilled Syringes Drug Revenue Market Share by Application (2019-2030)
5.3 Global Prefilled Syringes Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen Inc.
6.1.1 Amgen Inc. Corporation Information
6.1.2 Amgen Inc. Description and Business Overview
6.1.3 Amgen Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Inc. Prefilled Syringes Drug Product Portfolio
6.1.5 Amgen Inc. Recent Developments/Updates
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Teva Pharmaceutical Industries Ltd. Corporation Information
6.2.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Product Portfolio
6.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.3 AstraZeneca plc
6.3.1 AstraZeneca plc Corporation Information
6.3.2 AstraZeneca plc Description and Business Overview
6.3.3 AstraZeneca plc Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AstraZeneca plc Prefilled Syringes Drug Product Portfolio
6.3.5 AstraZeneca plc Recent Developments/Updates
6.4 Mylan N.V.
6.4.1 Mylan N.V. Corporation Information
6.4.2 Mylan N.V. Description and Business Overview
6.4.3 Mylan N.V. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan N.V. Prefilled Syringes Drug Product Portfolio
6.4.5 Mylan N.V. Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Prefilled Syringes Drug Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Fresenius Kabi AG
6.6.1 Fresenius Kabi AG Corporation Information
6.6.2 Fresenius Kabi AG Description and Business Overview
6.6.3 Fresenius Kabi AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fresenius Kabi AG Prefilled Syringes Drug Product Portfolio
6.6.5 Fresenius Kabi AG Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Prefilled Syringes Drug Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Prefilled Syringes Drug Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Merck & Co. Inc.
6.9.1 Merck & Co. Inc. Corporation Information
6.9.2 Merck & Co. Inc. Description and Business Overview
6.9.3 Merck & Co. Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck & Co. Inc. Prefilled Syringes Drug Product Portfolio
6.9.5 Merck & Co. Inc. Recent Developments/Updates
6.10 Novartis AG
6.10.1 Novartis AG Corporation Information
6.10.2 Novartis AG Description and Business Overview
6.10.3 Novartis AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Novartis AG Prefilled Syringes Drug Product Portfolio
6.10.5 Novartis AG Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prefilled Syringes Drug Industry Chain Analysis
7.2 Prefilled Syringes Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prefilled Syringes Drug Production Mode & Process
7.4 Prefilled Syringes Drug Sales and Marketing
7.4.1 Prefilled Syringes Drug Sales Channels
7.4.2 Prefilled Syringes Drug Distributors
7.5 Prefilled Syringes Drug Customers
8 Prefilled Syringes Drug Market Dynamics
8.1 Prefilled Syringes Drug Industry Trends
8.2 Prefilled Syringes Drug Market Drivers
8.3 Prefilled Syringes Drug Market Challenges
8.4 Prefilled Syringes Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
